IP Library Granted Patent US 12,595,233
Granted Patent B2
US 12,595,233 · App. 17/831,504 · Granted Apr 7, 2026

Thiosemicarbazates and uses thereof

Inventors: Yousef Al-Abed (Manhasset, NY); Ahmad Altiti (Manhasset, NY)
Assignee: THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
C07D209/48C07D403/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,595,233
App. No.
17/831,504
Granted
Apr 7, 2026
Kind
B2
Abstract

Thioesters, thiocarbamates, thiocarbazates, semithiocarbazates, peptides, aza-amino acid conjugates, and azapeptides; and a chemoselective and site-specific functionalization protocol of protected thiocarbazates and semithiocarbazates are described. The protocol features the use of Mitsunobu reaction to alkylate specifically the nitrogen atom close to the acylthiol moiety with alcohols to produce protected mono-substituted thiocarbazates that can be stored for months, activated under mild conditions at low temperature using halonium reagents and integrated orthogonally to make substituted semicarbazides that can be used, e.g., as synthons in synthesis of aza-amino acid conjugates, azapeptides and other peptidomimetics. Methods for preparing and using ureases, carbazides, semicarbazides, beta-peptides, azapeptides, and other peptidomimetics and azapeptide conjugates, and uses of ureases, carbazides, semicarbazides, beta-peptides, azapeptides in drug discovery, diagnosis, inhibition, prevention and treatment of diseases are also described.

Claims (73)

1 . A compound of the Formula (I):

wherein

A is a protecting group selected from the group consisting of tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl, carboxybenzyl, 2-(3,5-dimethoxyphenyl) propan-2-yloxycarbonyl, 2,2,4,6,7,-pendamethyl-dihydrobenzofuran-5-sulfonyl, triphenylmethyl, tert-butylcarbonyl, t-butoxy, allyloxycarbonyl, methoxytrimethylbenzene sulfonyl, 4,4-dimethoxy benzhydryl, 2,2,5,7,8-pentamethylchroman-6-sulfonyl, 2,4,6-trimethoxybenzyl, allylcarbonyl, and acetamidomethyl;

Y is NR 1 ;

X is NR 5 ;

D is H, Cl, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;

R 1 is H, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkoxyalkylene, optionally protected alkyl amine, or a side chain radical of an amino acid, which is unsubstituted or substituted; and

R 5 is H, an unsubstituted alkyl, unsubstituted alkoxy, substituted or unsubstituted alkoxyalkylene, optionally protected alkyl amine, or a side chain radical of an amino acid, which is substituted or unsubstituted, or an alkyl substituted one or more times by one or more substituents selected from the group consisting of halo, C 1 -C 6 alkyl, —COOR, —COR, methoxy, ethoxy, propoxy, C 1 -C 6 haloalkyl, and a protecting group, wherein R is an alkyl; or

R 1 and R 5 are together joined by —(CH 2 —CH 2 —CH 2 )—.

2 . The compound according to claim 1 , wherein A is selected from the group consisting of tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl, and carboxybenzyl.

3 . A compound of the Formula (I):

wherein

A is a protecting group selected from the group consisting of tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl, carboxybenzyl, 2-(3,5-dimethoxyphenyl) propan-2-yloxycarbonyl, 2,2,4,6,7,-pendamethyl-dihydrobenzofuran-5-sulfonyl, triphenylmethyl, tert-butylcarbonyl, t-butoxy, allyloxycarbonyl, methoxytrimethylbenzene sulfonyl, 4,4-dimethoxy benzhydryl, 2,2,5,7,8-pentamethylchroman-6-sulfonyl, 2,4,6-trimethoxybenzyl, allylcarbonyl, and acetamidomethyl;

Y is NR 1 ;

X is NR 5 ;

D is H, Cl, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;

R 1 is a radical of an amino acid, wherein the amino acid is selected from the group consisting of aspartic acid, phenylalanine, alanine, histidine, glutamic acid, tryptophan, valine, leucine, lysine, methionine, tyrosine, isoleucine, arginine, glycine, asparagine, serine, and glutamine, which are unsubstituted or substituted by one or more substituents selected from the group consisting of halo, C 1 -C 6 alkyl, —COOR, —COR, methoxy, ethoxy, propoxy, C 1 -C 6 haloalkyl, and a protecting group, wherein R is alkyl; and

R 5 is H, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkoxyalkylene, optionally protected alkyl amine, or a side chain radical of an amino acid, which is substituted or unsubstituted.

4 . A compound of the Formula (I):

wherein

A is a protecting group selected from the group consisting of tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl, carboxybenzyl, 2-(3,5-dimethoxyphenyl) propan-2-yloxycarbonyl, 2,2,4,6,7,-pendamethyl-dihydrobenzofuran-5-sulfonyl, triphenylmethyl, tert-butylcarbonyl, t-butoxy, allyloxycarbonyl, methoxytrimethylbenzene sulfonyl, 4,4-dimethoxy benzhydryl, 2,2,5,7,8-pentamethylchroman-6-sulfonyl, 2,4,6-trimethoxybenzyl, allylcarbonyl, and acetamidomethyl;

Y is NR 1 ;

X is NR 5 ;

D is H, Cl, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;

R 1 is H, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkoxyalkylene, optionally protected alkyl amine, or a side chain radical of an amino acid, which is unsubstituted or substituted; and

R 5 is a radical of an amino acid wherein the amino acid is selected from the group consisting of aspartic acid, phenylalanine, alanine, histidine, glutamic acid, tryptophan, valine, leucine, lysine, methionine, tyrosine, isoleucine, arginine, glycine, asparagine, serine, and glutamine, which are unsubstituted or substituted by one or more substituents selected from the group consisting of halo, a C 1 -C 6 alkyl, —COOR, —COR, methoxy, ethoxy, propoxy, C 1 -C 6 haloalkyl, and a protecting group, wherein R is alkyl.

5 . A compound of the Formula (I):

wherein

A is a protecting group selected from the group consisting of tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl, carboxybenzyl, 2-(3,5-dimethoxyphenyl) propan-2-yloxycarbonyl, 2,2,4,6,7,-pendamethyl-dihydrobenzofuran-5-sulfonyl, triphenylmethyl, tert-butylcarbonyl, t-butoxy, allyloxycarbonyl, methoxytrimethylbenzene sulfonyl, 4,4-dimethoxy benzhydryl, 2,2,5,7,8-pentamethylchroman-6-sulfonyl, 2,4,6-trimethoxybenzyl, allylcarbonyl, and acetamidomethyl;

Y is NR 1 ;

X is NR 5 ;

D is substituted or unsubstituted alkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl, and the substituents are selected from the group consisting of halo, C 1 -C 6 alkyl, —COOR, —COR, methoxy, ethoxy, propoxy, and C 1 -C 6 haloalkyl, wherein R is alkyl,

R 1 is H, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkoxyalkylene, optionally protected alkyl amine, or a side chain radical of an amino acid, which is unsubstituted or substituted; and

R 5 is H, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkoxyalkylene, optionally protected alkyl amine, or a side chain radical of an amino acid, which is substituted or unsubstituted.

6 . The compound according to claim 1 , A compound of the Formula (I):

wherein

A is a protecting group selected from the group consisting of tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl, carboxybenzyl, 2-(3,5-dimethoxyphenyl) propan-2-yloxycarbonyl, 2,2,4,6,7,-pendamethyl-dihydrobenzofuran-5-sulfonyl, triphenylmethyl, tert-butylcarbonyl, t-butoxy, allyloxycarbonyl, methoxytrimethylbenzene sulfonyl, 4,4-dimethoxy benzhydryl, 2,2,5,7,8-pentamethylchroman-6-sulfonyl, 2,4,6-trimethoxybenzyl, allylcarbonyl, and acetamidomethyl;

Y is NR 1 ;

X is NR 5 ;

D is H, Cl, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl,

R 1 is a radical of an amino acid wherein the amino acid is an unnatural amino acid, and

R 5 is H, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkoxyalkylene, optionally protected alkyl amine, or a side chain radical of an amino acid, which is substituted or unsubstituted.

7 . The compound according to claim 1 , A compound of the Formula (I):

wherein

A is a protecting group selected from the group consisting of tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl, carboxybenzyl, 2-(3,5-dimethoxyphenyl) propan-2-yloxycarbonyl, 2,2,4,6,7,-pendamethyl-dihydrobenzofuran-5-sulfonyl, triphenylmethyl, tert-butylcarbonyl, t-butoxy, allyloxycarbonyl, methoxytrimethylbenzene sulfonyl, 4,4-dimethoxy benzhydryl, 2,2,5,7,8-pentamethylchroman-6-sulfonyl, 2,4,6-trimethoxybenzyl, allylcarbonyl, and acetamidomethyl;

Y is NR 1 ;

X is NR 5 ;

D is H, Cl, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl,

R 1 is H, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkoxyalkylene, optionally protected alkyl amine, or a side chain radical of an amino acid, which is unsubstituted or substituted; and

R 5 is a radical of an amino acid wherein the amino acid is an unnatural amino acid.

8 . The compound according to claim 1 , which is of the formula:

9 . The compound according to claim 8 , wherein A is selected from the group consisting of tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl, and carboxybenzyl.

10 . The compound according to claim 1 , which is of the formula:

wherein R 9 is H, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, alkoxyalkylene, optionally protected alkyl amine, or a side chain radical of an amino acid, which is substituted or unsubstituted.

11 . A compound of the Formula (V):

wherein

A is a protecting group selected from the group consisting of tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl, carboxybenzyl, 2-(3,5-dimethoxyphenyl) propan-2-yloxycarbonyl, 2,2,4,6,7,-pendamethyl-dihydrobenzofuran-5-sulfonyl, triphenylmethyl, tert-butylcarbonyl, t-butoxy, allyloxycarbonyl, methoxytrimethylbenzene sulfonyl, 4,4-dimethoxy benzhydryl, 2,2,5,7,8-pentamethylchroman-6-sulfonyl, 2,4,6-trimethoxybenzyl, allylcarbonyl, and acetamidomethyl;

D is H, Cl, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and

R 10 is H, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkoxyalkylene, optionally protected alkyl amine, or a side chain radical of an amino acid, which is substituted or unsubstituted.

12 . The compound according to claim 1 , wherein R 1 is a radical of an amino acid, wherein the amino acid is selected from the group consisting of aspartic acid, phenylalanine, alanine, histidine, glutamic acid, tryptophan, valine, leucine, lysine, methionine, tyrosine, isoleucine, arginine, glycine, asparagine, serine, and glutamine, which are unsubstituted or substituted by one or more substituents selected from the group consisting of halo, C 1 -C 6 alkyl, —COOR, —COR, methoxy, ethoxy, propoxy, C 1 -C 6 haloalkyl, and a protecting group, wherein R is alkyl.

13 . The compound according to claim 12 , wherein R 5 is a radical of an amino acid, wherein the amino acid is selected from the group consisting of aspartic acid, phenylalanine, alanine, histidine, glutamic acid, tryptophan, valine, leucine, lysine, methionine, tyrosine, isoleucine, arginine, glycine, asparagine, serine, and glutamine, which are unsubstituted or substituted by one or more substituents selected from the group consisting of halo, C 1 -C 6 alkyl, —COOR, —COR, methoxy, ethoxy, propoxy, C 1 -C 6 haloalkyl, and a protecting group, wherein R is alkyl.

14 . A process for synthesizing an aza-peptide comprising activating an acyl thiol with TCCA or a combination of TCCA and TBACl to form an acyl chloride and coupling the acyl chloride with an amine, wherein the acyl thiol is a compound according to claim 1 .

15 . A process for preparing a compound according to claim 1 , which comprises forming the compound by reacting a semi-protected hydrazine with chlorothioformate to form an S-alkylthiocarbazate, and alkylating the resulting S-alkylthiocarbazate selectively via Mitsunobu reaction, a direct alkylation with a combination of NaH or Barton's base and an alkyl halide.

16 . The compound according to claim 1 , wherein:

R 1 is H, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkoxyalkylene, optionally protected alkyl amine, or a side chain radical of an amino acid, which is unsubstituted or substituted; and

R 5 is substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkoxyalkylene, optionally protected alkyl amine, or a side chain radical of an amino acid, which is substituted or unsubstituted.

17 . The compound according to claim 1 , wherein:

R 1 is H, substituted or unsubstituted alkyl, or a side chain radical of an amino acid, which is unsubstituted or substituted; and

R 5 is substituted or unsubstituted alkyl, or a side chain radical of an amino acid, which is substituted or unsubstituted.

18 . The compound according to claim 1 , wherein A is fluorenylmethoxycarbonyl.

19 . The compound according to claim 1 , wherein D is ethyl.

20 . The compound according to claim 1 , wherein A is fluorenylmethoxycarbonyl, and D is ethyl.

21 . The compound according to claim 1 , wherein A is 9-fluorenylmethoxycarbonyl, R 1 is H; and D is ethyl.

Continuity (3)
Division 16869749 · May 8, 2020
Provisional Application 62845694 · May 9, 2019
Related Publication 20220306577A1 · Sep 29, 2022
References Cited (55)
US 4282169A · Rothgery · 1981 [cited by applicant]
US 4713381A · Ao · 1987 [cited by applicant]
US 5602231A · Cotton et al. · 1997 [cited by applicant]
US 7531533B2 · Shoda · 2009 [cited by examiner]
US 8563565B2 · Norimine et al. · 2013 [cited by applicant]
US 9186371B2 · Taniguchi et al. · 2015 [cited by applicant]
US 10919882B2 · Al-Abed et al. · 2021 [cited by applicant]
US 11414405B2 · Al-Abed et al. · 2022 [cited by applicant]
US 11440881B2 · Al-Abed et al. · 2022 [cited by applicant]
US 11471507B2 · Al-Abed et al. · 2022 [cited by applicant]
US 11471508B2 · Al-Abed et al. · 2022 [cited by applicant]
US 11524048B2 · Al-Abed · 2022 [cited by applicant]
US 20060281686A1 · Lopez Areiza et al. · 2006 [cited by applicant]
US 20110086836A1 · Soeberdt et al. · 2011 [cited by applicant]
US 20180344808A1 · Tracey et al. · 2018 [cited by applicant]
US 20190055283A1 · Ekici et al. · 2019 [cited by applicant]
US 20200354404A1 · Al-Abed · 2020 [cited by applicant]
US 20200354418A1 · Al-Abed · 2020 [cited by applicant]
US 20210188837A1 · Shikanai et al. · 2021 [cited by applicant]
US 20220372022A1 · Al-Abed et al. · 2022 [cited by applicant]
CN 101932568A · 2010 [cited by applicant]
EP 1847533A1 · 2007 [cited by applicant]
GB 826300 · 1959 [cited by applicant]
JP 2001075232A · 2001 [cited by applicant]
WO WO0140515A1 · 2001 [cited by applicant]
WO WO2009096609A1 · 2009 [cited by applicant]
WO WO2016094899A2 · 2016 [cited by applicant]
WO WO2019131582A1 · 2019 [cited by applicant]
Cécile Abbas et al., “Original and efficient synthesis of 2:1-[α/aza]-oligomer precursors”, Tetrahedron Letters, vol. 50, No. 28, pp. 4158-4160, Jul. 15, 2009. [cited by applicant]
Noam S. Freeman et al., “Microwave-Assisted Solid-Phase Aza-peptide Synthesis: Aza Scan of a PKB/Akr Inhibitor Using Aza-arginine and Aza-proline Precursors”, The Journal of Organic Chemistry, vol. 76, No. 9, pp. 3078-3… [cited by applicant]
Mariappan Anbazhagan et al., “Conversion of Carbonimidodithioates into Unsymmetrical Di- and tri-substituted. Ureas including Urea Dipeptides”, Tetrahedron Letters, vol. 39, No. 21, pp. 3609-3612, 1998. [cited by applicant]
European Search Report issued on Dec. 19, 2022, in corresponding European Application No. EP 20 80 2822. [cited by applicant]
Nathalie Ollivier et al., “Silver Catalyzed azaGly Ligation. Application to the Synthesis of Azapeptides and of Lipid-Peptide Conjugates”, Bioconjugate Chem, vol. 20, pp. 1397-1403, 2009. [cited by applicant]
Ramesh Chingle et al., “Azapeptide Synthesis Methods for Expanding Side-Chain Diversity for Biomedical Applications”, Accounts of Chemical Research, vol. 50, pp. 1541-1556, 2017. [cited by applicant]
Branka Zorc et al., “Benzotriazole as a Synthetic Auxiliary”, Croatica Chemica Acta, 85(4), pp. 959-601, 2012. [cited by applicant]
Ye Che et al., “Impact of Cis-Proline Analogs Peptide Conformation”, Biopolymers, vol. 81, pp. 392-406, 2006. [cited by applicant]
Harper, H.A. et al. “Review of physiological chemistry” [cited by applicant]
Carine B. Bourguet et al., “Solution-phase submonomer diversification of the aza-dipeptide building blocks and their application in aza-peptide and aza-DKP synthesis”, Journal of Peptide Science, vol. 16, No. 6, Jun. 1,… [cited by applicant]
International Search Report issued on Sep. 2, 2020, from corresponding International Application No. PCT/US20/31998. [cited by applicant]
Written Opinion of the International Searching Authority issued on Sep. 2, 2020, from corresponding International Application No. PCT/US20/31998. [cited by applicant]
PubChem CID-136595533 “(2,5-Dioxopyrrol-1-yl) N-(2,5-dihydroxypyrrol-1-yl)-N-(1,3-dioxoisoindol-2-yl)carbamate” Created on Jan. 4, 2019. [cited by applicant]
PubChem CID-132255576 “(2S)-2-(Imidazole-1-carbonylamino)pentanedioic acid” Created on Jan. 29, 2018. [cited by applicant]
International Search Report issued on Jul. 31, 2020, from corresponding International Application No. PCT/US20/32025. [cited by applicant]
Written Opinion of the International Searching Authority issued on Jul. 31, 2020, from corresponding International Application No. PCT/US20/32025. [cited by applicant]
Yang et al. “MD-2 is required for disulfide HMGB1-dependent TLR4 signaling” The Journal of Experimental Medicine; Published on Jan. 5, 2015; vol. 212; p. 5-14. [cited by applicant]
Sun et al. “Folic acid derived-P5779 mimetics regulate DAMP-mediated inflammation through disruption of HMGB1:TLR4: MD-2 axes” PLOS One; Published on Feb. 15, 2018; vol. 13; p. 1-14. [cited by applicant]
International Search Report issued on Sep. 10, 2020, from corresponding International Application No. PCT/US20/31992. [cited by applicant]
Written Opinion of the International Searching Authority issued on Sep. 10, 2020, from corresponding International Application No. PCT/US20/31992. [cited by applicant]
PubChem CID-519335 “Methanethioic S-acid” Created on Mar. 27, 2005. [cited by applicant]
Heffeter et al. “Anticancer Thiosemicarbazones: Chemical Properties, Interaction with Iron Metabolism, and Resistance Development” ANTIOXIDANTS & Redox Signaling; vol. 30, No. 8, 2019. [cited by applicant]
International Search Report issued on Sep. 16, 2020, from corresponding International Application No. PCT/US20/31988. [cited by applicant]
Written Opinion of the International Searching Authority issued on Sep. 16, 2020, from corresponding International Application No. PCT/US20/31988. [cited by applicant]
PubChem CID-67548889 “Methyl (2S)-1-(imidazole-1-carbonyl)pyrrolidine-2-carboxylate” Created on Nov. 30, 2012. [cited by applicant]
PubChem CID-1089188 “(2s)-1-(1-Imidazolylcarbonyl)pyrrolidine-2-carboxylic acid benzyl ester” Created on Oct. 26, 2006. [cited by applicant]
Riemschneider, R. JACS 1955, 844-847. [cited by applicant]